Demant A/S (WILYY)
OTCMKTS · Delayed Price · Currency is USD
19.25
0.00 (0.00%)
At close: Sep 10, 2025
Demant Market Cap
Demant has a market cap or net worth of $7.98 billion as of September 19, 2025. Its market cap has decreased by -13.39% in one year.
Market Cap
7.98B
Enterprise Value
10.35B
Revenue
3.56B
Ranking
n/a
PE Ratio
21.98
Stock Price
$19.25
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 388.01M to 7.98B, an increase of 1,955.50%. That is a compound annual growth rate of 10.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 7.98B | -0.36% |
| Dec 30, 2024 | 8.00B | -15.86% |
| Dec 29, 2023 | 9.51B | 56.03% |
| Dec 30, 2022 | 6.10B | -50.08% |
| Dec 30, 2021 | 12.21B | 28.27% |
| Dec 30, 2020 | 9.52B | 23.21% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Tian'an Technology Group | 719.18M |
| Elite Pharmaceuticals | 697.08M |
| Glass House Brands | 575.59M |
| Northwest Biotherapeutics | 378.39M |
| Nika Pharmaceuticals | 370.64M |
| CytoDyn | 352.05M |
| American Oncology Network | 340.34M |